BlackRock Health Sciences Term Trust (NYSE:BMEZ) to Issue Monthly Dividend of $0.11

BlackRock Health Sciences Term Trust (NYSE:BMEZ) declared a monthly dividend on Monday, November 3rd. Investors of record on Friday, November 14th will be paid a dividend of 0.11 per share on Friday, November 28th. This represents a c) dividend on an annualized basis and a yield of 8.9%. The ex-dividend date of this dividend is Friday, November 14th.

BlackRock Health Sciences Term Trust Price Performance

Shares of NYSE BMEZ opened at $14.87 on Tuesday. BlackRock Health Sciences Term Trust has a 1 year low of $12.58 and a 1 year high of $16.75. The firm has a 50-day moving average of $14.62 and a 200 day moving average of $14.39.

Hedge Funds Weigh In On BlackRock Health Sciences Term Trust

Large investors have recently modified their holdings of the stock. LPL Financial LLC raised its position in shares of BlackRock Health Sciences Term Trust by 2.3% in the 1st quarter. LPL Financial LLC now owns 195,565 shares of the company’s stock worth $2,914,000 after purchasing an additional 4,397 shares during the last quarter. Royal Bank of Canada raised its position in shares of BlackRock Health Sciences Term Trust by 326.9% in the 1st quarter. Royal Bank of Canada now owns 1,594,157 shares of the company’s stock worth $23,753,000 after purchasing an additional 1,220,764 shares during the last quarter. Brown Lisle Cummings Inc. raised its position in shares of BlackRock Health Sciences Term Trust by 1.9% in the 2nd quarter. Brown Lisle Cummings Inc. now owns 45,112 shares of the company’s stock worth $643,000 after purchasing an additional 852 shares during the last quarter. Nova Wealth Management Inc. purchased a new position in shares of BlackRock Health Sciences Term Trust in the 1st quarter worth about $39,000. Finally, SeaCrest Wealth Management LLC raised its position in shares of BlackRock Health Sciences Term Trust by 9.1% in the 2nd quarter. SeaCrest Wealth Management LLC now owns 26,800 shares of the company’s stock worth $382,000 after purchasing an additional 2,245 shares during the last quarter.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Trust II’s (BMEZ) (the ‘Trust’) investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of companies principally engaged in the health sciences group of industries and equity derivatives with exposure to the health sciences group of industries.